Literature DB >> 20091777

BDNF+/- mice exhibit deficits in oligodendrocyte lineage cells of the basal forebrain.

Melissa W Vondran1, Patricia Clinton-Luke, Jean Z Honeywell, Cheryl F Dreyfus.   

Abstract

Previous work indicated that brain-derived neurotrophic factor (BDNF), through the trkB receptor, increases DNA synthesis in oligodendrocyte (OLG) progenitor cells (OPCs) and differentiation of postmitotic OLGs of the basal forebrain (BF). In the present studies, BDNF knockout animals were used to investigate BDNF's effects on OLG lineage cells (OLCs) in vivo. OLCs of the BF were found to express the trkB receptor, suggesting they are responsive to BDNF. Immunohistochemistry using NG2 and CC1 antibodies was utilized to examine the numbers of NG2+ OPCs and CC1+ postmitotic BF OLGs. At embryonic day 17 (E17), BDNF-/- animals display reduced NG2+ cells. This reduction was also observed in BDNF+/- mice at E17 and at postnatal day 1 (P1), P14, and adult stage, suggesting that BDNF plays a role in OPC development. BDNF+/- mice do not exhibit deficits in numbers of CC1+ OLGs. However, myelin basic protein, myelin associated glycoprotein, and proteolipid protein are reduced in BDNF+/- mice, suggesting that BDNF plays a role in differentiation. These data indicate that progenitor cells and myelin proteins may be affected in vivo by a decrease in BDNF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091777      PMCID: PMC2851835          DOI: 10.1002/glia.20969

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  59 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Neurotrophin-4/5 promotes proliferation of oligodendrocyte-type-2 astrocytes (O-2A).

Authors:  I A Scarisbrick; K Asakura; M Rodriguez
Journal:  Brain Res Dev Brain Res       Date:  2000-09-30

3.  Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.

Authors:  David Azoulay; Veronika Vachapova; Boris Shihman; Ariel Miler; Arnon Karni
Journal:  J Neuroimmunol       Date:  2005-10       Impact factor: 3.478

4.  Heterozygous knock-out mice for brain-derived neurotrophic factor show a pathway-specific impairment of long-term potentiation but normal critical period for monocular deprivation.

Authors:  Alessandro Bartoletti; Laura Cancedda; Susan W Reid; Lino Tessarollo; Vittorio Porciatti; Tommaso Pizzorusso; Lamberto Maffei
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

5.  Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Neuropathol Appl Neurobiol       Date:  1984 May-Jun       Impact factor: 8.090

Review 6.  Brain-derived neurotrophic factor: a newly described mediator of angiogenesis.

Authors:  Pouneh Kermani; Barbara Hempstead
Journal:  Trends Cardiovasc Med       Date:  2007-05       Impact factor: 6.677

7.  Regionally specific effects of BDNF on oligodendrocytes.

Authors:  Yangzhou Du; Tanya Z Fischer; Lucille N Lee; Lauren D Lercher; Cheryl F Dreyfus
Journal:  Dev Neurosci       Date:  2003 Mar-Aug       Impact factor: 2.984

8.  Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms.

Authors:  B Fontaine; D Seilhean; A Tourbah; C Daumas-Duport; C Duyckaerts; N Benoit; B Devaux; J J Hauw; G Rancurel; O Lyon-Caen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

9.  Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function.

Authors:  S Elkabes; E M DiCicco-Bloom; I B Black
Journal:  J Neurosci       Date:  1996-04-15       Impact factor: 6.167

10.  Mice lacking brain-derived neurotrophic factor develop with sensory deficits.

Authors:  P Ernfors; K F Lee; R Jaenisch
Journal:  Nature       Date:  1994-03-10       Impact factor: 49.962

View more
  55 in total

Review 1.  Oligodendrocyte Development and Plasticity.

Authors:  Dwight E Bergles; William D Richardson
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

2.  Non-invasive Brain Delivery and Efficacy of BDNF in APP/PS1 Transgenic Mice as a Model of Alzheimer's Disease.

Authors:  Brian M Kopec; Liqin Zhao; Eduardo Rosa-Molinar; Teruna J Siahaan
Journal:  Med Res Arch       Date:  2020-02

3.  Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.

Authors:  Miki Furusho; Akihiro Ishii; Rashmi Bansal
Journal:  J Neurosci       Date:  2017-02-13       Impact factor: 6.167

4.  Cortical spreading depolarization stimulates gliogenesis in the rat entorhinal cortex.

Authors:  Anja Urbach; Judith Brueckner; Otto W Witte
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

Review 5.  Glial development: the crossroads of regeneration and repair in the CNS.

Authors:  Vittorio Gallo; Benjamin Deneen
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

Review 6.  The role of growth factors as a therapeutic approach to demyelinating disease.

Authors:  Yangyang Huang; Cheryl F Dreyfus
Journal:  Exp Neurol       Date:  2016-03-22       Impact factor: 5.330

7.  Loss of Adaptive Myelination Contributes to Methotrexate Chemotherapy-Related Cognitive Impairment.

Authors:  Anna C Geraghty; Erin M Gibson; Reem A Ghanem; Jacob J Greene; Alfonso Ocampo; Andrea K Goldstein; Lijun Ni; Tao Yang; Rebecca M Marton; Sergiu P Paşca; Michael E Greenberg; Frank M Longo; Michelle Monje
Journal:  Neuron       Date:  2019-05-20       Impact factor: 17.173

Review 8.  Wrapped to Adapt: Experience-Dependent Myelination.

Authors:  Christopher W Mount; Michelle Monje
Journal:  Neuron       Date:  2017-08-16       Impact factor: 17.173

9.  ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination.

Authors:  Akihiro Ishii; Sharyl L Fyffe-Maricich; Miki Furusho; Robert H Miller; Rashmi Bansal
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

Review 10.  Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.

Authors:  Anna J Khalaj; Jonathan Hasselmann; Catherine Augello; Spencer Moore; Seema K Tiwari-Woodruff
Journal:  J Steroid Biochem Mol Biol       Date:  2016-01-14       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.